Treatment of uterovaginal prolapse with chaale babool

Effect of Chaale babool in Uterovaginal Prolapse A Randomized Comparative trial

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/05/042941

Enrollment

Registered

2022-05-31

Start date

Unknown

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N812- Incomplete uterovaginal prolapse

Interventions

Intervention1: Chaale babool: Sitz bath with decoction of chaale babool once in a day will be done along with PFMT for 8 weeks. Decoction will be made by adding 25gms of chaale babool in 2.5liters of

Eligibility

Inclusion criteria

Inclusion criteria: Parous women between 30 to 45 years of ages Diagnosed cases of 1st and 2nd degree by POP-Q system of grading prolapse

Exclusion criteria

Exclusion criteria: Pregnant and lactating women Patients with recurrent urinary tract infection and sexually transmitted diseases Patients with organic pelvic pathology Patients with systemic and metabolic illnesses Unhealthy cervix (suspected lesions)

Design outcomes

Primary

Measure	Time frame
PFIQ-7 and PFDI-20 questionnaireTimepoint: At Baseline 14th day 28th day 42th day 60th day	—

Secondary

Measure	Time frame
Stress test Pelvic muscle strength assessed by modified oxford grading scale. POP-Q system of grading prolapseTimepoint: At Baseline 14th day 28th day 42th day 60th day	—

Countries

India

Contacts

Public ContactDr Nikhat Kausar Inamdar

Luqman Unani Medical College Hospital and Research Centre

aqilquadri@yahoo.com9849090182

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026